Keywords: Talecris, Manufacturing plant expansion, Investment

Talecris to invest $268.7 million to expand Clayton manufacturing plant

Article | 17 November 2009

US drugmaker Talecris says it will spend $268.7 million to expand its manufacturing facilities in Clayton, North Carolina, creating 259 new jobs over the next seven years. State and local tax credits and incentive grants will be provided to facilitate the expansion.

Mary Kuhn, executive vice president of operations at Talecris, said:  “Our manufacturing capabilities have grown exponentially in recent years, creating more jobs and local opportunities. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in